Assistant Professor Carlijn Van der Aalst
Erasmus University Medical Centre, Rotterdam (Netherlands (The))
Risk results from screening for a high cardiovascular disease risk by means of traditional risk factor measurement or coronary artery calcium scoring in the ROBINSCA trial
Event: ESC Congress 2020
Topic: Secondary Prevention
Session: Risk Factors and Prevention ePosters
Risk Or Benefit IN Screening for CArdiovascular Disease (ROBINSCA): the rationale and study design of a population-based randomised-controlled screening trial for cardiovascular disease
Event: EuroPrevent 2019
Topic: Secondary Prevention
Session: Risk Factors and Prevention - Secondary Prevention
ESC 365 is supported by
